| Document Date: 2015-01-08 01:31:12
Open Document File Size: 427,26 KBShare Result on Facebook
City Philadelphia / Lyon / Paris / / Company CAC Pharm / TEVA / ERYTECH / Recordati Group / / Continent Europe / / Country France / United States / Israel / / Currency EUR / / / Event FDA Phase / Employment Change / Business Partnership / / IndustryTerm biopharmaceutical / operational manufacturing site / / MedicalCondition leukemia / cancer / acute leukemia / solid tumor / solid tumors / tumor starvation / Acute Lymphoblastic Leukemia / pancreas cancer / Acute Myeloid Leukemia / / Person Julien Perez / Pierre-Olivier Goineau / Gil Beyen / Emmanuel Huynh / / / Position one of the co-founders / Chairman and CEO / Vice President and COO / co-founder and CEO / Chairman & CEO / COO / / Product ALL / Acute Myeloid Leukemia / Acute Lymphoblastic Leukemia / / URL www.erytech.com / /
SocialTag |
PRESS RELEASE PRESS RELEASE ERYTECH announces management change